CAC
DRNA

Certified Advisory Corp’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Certified Advisory Corp’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$13K – 795
2021
Q1 		$13K Buy
+500
New +$12.8K ﹤0.01% 569

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Certified Advisory Corp's DRNA Position: Q2 2021 in Review

Certified Advisory Corp sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 500 shares — an estimated $13K sold.

Certified Advisory Corp first reported a position in DRNA in Q1 2021 and held it in 1 quarter. The position peaked at $13K in Q1 2021. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

  • Certified Advisory Corp reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Certified Advisory Corp sold 500 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $13K.
  • Certified Advisory Corp first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • Certified Advisory Corp's Dicerna Pharmaceuticals, Inc. position peaked at $13K in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.